Kyinno Bio

Kyinno Bio

Private
BeijingHealthcare & Life Scienceshttps://www.kyinno.com/

Last Round

Series B

Dec 15, 2025

Total Funding Raised

$58.8M

Company Overview

Kyinno Bio is a biotechnology company that operates as a preclinical contract research organization (CRO) specializing in customized services, including in vitro and in vivo pharmacology, cell line engineering, and antibody discovery to accelerate cancer drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

preclinical CROcontract research organizationCROoncology drug discoveryantibody discoverycell line engineeringin vivo servicesin vitro servicesengineered cell linesdrug discovery AIcomputer-aided drug designin-silico screeningtransgenic mouse modelstarget identificationbispecific antibodiesmembrane protein screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kyinno Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kyinno Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BDec 15, 2025
Series A ExtensionNov 29, 2021
Series AApr 1, 2021
AngelJul 10, 2017

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 15, 2025

    $36M round led by Beijing E-Town International Investment & Development Co., Ltd.

  • Nov 29, 2021

    $16M round led by MPCi

Kyinno Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kyinno Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kyinno Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range2
Year Founded2017
Last FundingDec 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.